Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management; A 104-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Obese Patients

NCT00395135 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00395135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00395135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management; A 104-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Obese Patients
Lead sponsor
Eisai Inc.
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2006
Completion date
February 28, 2009
Enrollment
3,182 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity